Related Experiment Videos

Current issues in viral assays and viral clearance evaluation

A S Lubiniecki1

  • 1SmithKline Beecham Pharmaceuticals, King of Prussia PA, USA.

Developments in Biological Standardization
|January 1, 1996
PubMed
Summary

Detecting viral contaminants in biopharmaceuticals is challenging due to assay limitations. A combination of rigorous testing, process controls, and viral clearance methods is essential to prevent virus infection in patients.

Related Concept Videos